Overview

Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine if difluprednate ophthalmic emulsion is effective in reducing the ocular symptoms of dry eye disease, as measured by a global Visual Analog Scale (VAS) discomfort score.
Phase:
Phase 2
Details
Lead Sponsor:
Alcon Research
Treatments:
Anti-Inflammatory Agents
Difluprednate
Fluprednisolone